Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-6356 Phase 2b in Parkinson's Disease
NCT03703570Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sipagladenant in Parkinson's disease (PD), sponsored by Kyowa Kirin. Started Sep 2018; status: completed.
02
Drugs
sipagladenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03703570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03703570.